Michael Kuchenreuther, PhD, is a research analyst,
at Numerof & Associates, Inc.
The authors take a look at some of the recent developments in the German pharmaceutical market.
Data analytic strategies can help companies capitalize on personalized medicine.
Biopharma companies should not overlook India's growing market.
Israel's diverse population, high-quality healthcare system, and resilience to global financial stress make it a strong partner for R'D, clinical research, and market growth.